DUAL II China: Superior HbA1c reductions and weight loss with insulin degludec/liraglutide (IDegLira) versus insulin degludec in a randomized trial of Chinese people with type 2 diabetes inadequately controlled on basal insulin
For many patients, this means consistent therapy, customized dosing, and a more comfortable, supportive approach to long-term weight management
Some Medicare subscribers will be able to have weight-loss drugs covered by their plans
GLP-1 acts as a potent incretin, stimulating glucose-dependent insulin secretion postprandially
Moreover, in facing various pathological challenges, the mammalian heart, which possesses high levels of mitochondria and weak antioxidant capacity, is susceptible to oxidant production and oxidative damage
The 2.5 mg solution looks the same as the 15 mg solution inside the pen